Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
AstraZeneca PLC banner

AstraZeneca PLC
NYSE:AZN

Watchlist Manager
AstraZeneca PLC Logo
AstraZeneca PLC
NYSE:AZN
Watchlist
Price: 174.095 USD -7.6%
Market Cap: $270B
Write Note Create Alert Ask AI

Wall St Price Targets

AZN Price Targets Summary
AstraZeneca PLC

Wall Street analysts forecast AZN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AZN is 223.363 USD with a low forecast of 152.421 USD and a high forecast of 260.823 USD.

AZN Lowest Forecast
Wall Street Target
$152.421
-12% Downside
AZN Average Forecast
Wall Street Target
$223.363
28% Upside
AZN Highest Forecast
Wall Street Target
$260.823
50% Upside
Lowest Forecast
Price Target
152.421 USD
12% Downside
Average Forecast
Price Target
223.363 USD
28% Upside
Highest Forecast
Price Target
260.823 USD
50% Upside
AstraZeneca PLC Competitors:
Price Targets
I
IMRX
Immuneering Corp
305% Upside
O
OBT
Orange County Bancorp Inc
2% Upside
I
IMRX
Immuneering Corp
305% Upside
O
OBT
Orange County Bancorp Inc
2% Upside

Revenue
Forecast

6% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
6% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 5%.

What are analyst estimates?

Gross Profit
Forecast

6% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
6% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 8 years is 5%.

What are analyst estimates?

Operating Income
Forecast

4% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-37%
Average Miss
4% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-37%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 11%.

What are analyst estimates?

Pre-Tax Income
Forecast

4% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-50%
Average Miss
4% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-50%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 26%.

What are analyst estimates?

Net Income
Forecast

4% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-49%
Average Miss
4% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-49%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 12%.

What are analyst estimates?

Continue AZN Research

Summary
AZN intrinsic value, competitors valuation, and company profile.
DCF Valuation
AZN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AZN stock valuation using valuation multiples.
Wall St Estimates
AZN price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AZN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other AstraZeneca PLC listings:
NASDAQ • USD
AZN
 OTC • USD
AZNCF
 LSE • GBX
AZN
 LSE • USD
0A4J
 XETRA • EUR
ZEG
 F • EUR
ZEGA
 F • EUR
ZEG
 XBER • EUR
ZEG
 XBER • EUR
ZEGA
 XHAM • EUR
ZEG
 STO • SEK
AZN
 BMV • MXN
AZNN
 XMUN • EUR
ZEGA
 XMUN • EUR
ZEG
 SWB • EUR
ZEG
 SWB • EUR
ZEGA
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is AZN's stock price target?
Price Target
223.363 USD

According to Wall Street analysts, the average 1-year price target for AZN is 223.363 USD with a low forecast of 152.421 USD and a high forecast of 260.823 USD.

What is the Revenue forecast for AstraZeneca PLC?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 5%.

What is the Gross Profit forecast for AstraZeneca PLC?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 8 years is 5%.

What is the Operating Income forecast for AstraZeneca PLC?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 11%.

What is the Pre-Tax Income forecast for AstraZeneca PLC?
Projected CAGR
26%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 26%.

What is the Net Income forecast for AstraZeneca PLC?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 12%.

Back to Top
ALPHA SPREAD
Follow us
Join 350,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett